MOLOGEN AG: Dr med Stefan M. Manth appointed as new CEO of MOLOGEN AG
MOLOGEN AG / Key word(s): Personnel
Publication of an insider information pursuant to Section 17 of the regulation (EU) No. 596/2014
Berlin, 27 March 2019 - The Supervisory Board of MOLOGEN AG (ISIN DE000A2LQ900 / SIN A2L Q90) (the "Company") today appointed Dr med Stefan M. Manth, previously Vice Chairman of the Supervisory Board, as Member of the Executive Board and new Chief Executive Officer (CEO) of MOLOGEN AG shortly with effect after the completion of the ongoing capital increase.
Note about risk for future predictions
27-March-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||030 / 841788-0|
|Fax:||030 / 841788-50|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||792363|
|End of Announcement||DGAP News Service|